Clozapine could be an effective alternative for treatment-resistant schizophrenia patients

New findings, published recently in the American Journal of Psychiatry, have revealed that clozapine may be the best alternative when patients are unresponsive to standard antipsychotic medications for schizophrenia. The research was carried out at Columbia University Medical Center (NY, USA). Schizophrenia affects up to 1% of the adult population in the USA, but despite antipsychotics successfully relieving symptoms in most patients, up to 30% of patients have treatment-resistant schizophrenia. Prior to this study, clozapine was often considered a last resort for schizophrenia patients due to concerns over the risk of agranulocytosis, despite it being the only medication approved by...